TISEO, Marcello
TISEO, Marcello
Dipartimento di Medicina e Chirurgia
"Pseudocavitation" in thymic carcinoma during treatment with sunitinib
2013-01-01 Tiseo, M.; Rajan, A.; Thomas, A.; Giaccone, G.
'Turban-like' skull metastasis from pulmonary adenocarcinoma
2017-01-01 Mengoli, M. C.; Rossi, G.; Tiseo, M.; Barbieri, F.; Pifferi, M.; Bertolini, F.; Lococo, F.
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
2021-01-01 Mazzaschi, G.; Scandino, R.; Milanese, G.; Pavone, C.; Maurizio, B.; Silva, M.; Ledda, R.; Minari, R.; Trentini, F.; Buti, S.; Bordi, P.; Leonetti, A.; Quaini, F.; Sverzellati, N.; Romanel, A.; Tiseo, M.
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients
2021-01-01 Mazzaschi, G.; Milanese, G.; Moron Dalla Tor, L.; Leo, L.; Balbi, M.; Trentini, F.; Manini, M.; Pavone, C.; Silva, M.; Ledda, R. E.; Minari, R.; Bordi, P.; Buti, S.; Leonetti, A.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
209P: SMO mutation is a strong negative prognostic factor in malignant pleural mesothelioma
2016-01-01 Signorelli, D.; Proto, C.; Ganzinelli, M.; Russo, G. L.; Botta, L.; Trama, A.; Pasello, G.; Tiseo, M.; Pelosi, G.; Garassino, M.
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors
2022-01-01 Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
2PD Monitoring of secondary drug resistance mutations in circulating tumor DNA of patients with advanced ALK positive NSCLC
2016-01-01 Bordi, P.; Del Re, M.; Danesi, R.; Tiseo, M.
A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?
2021-01-01 Leonetti, A.; Carbone, D.; Gregori, A.; Tiseo, M.; Peters, G. J.; Deng, D.; Giovannetti, E.
A metanalysis on cabozantinib and bone metastases: True story or commercial gimmick?
2020-01-01 Bersanelli, M.; Buti, S.; Ghidini, A.; Tiseo, M.; Petrelli, F.
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable
2019-01-01 Cortellini, Alessio; Bersanelli, Melissa; Buti, Sebastiano; Cannita, Katia; Santini, Daniele; Perrone, Fabiana; Giusti, Raffaele; Tiseo, Marcello; Michiara, Maria; Di Marino, Pietro; Tinari, Nicola; De Tursi, Michele; Zoratto, Federica; Veltri, Enzo; Marconcini, Riccardo; Malorgio, Francesco; Russano, Marco; Anesi, Cecilia; Zeppola, Tea; Filetti, Marco; Marchetti, Paolo; Botticelli, Andrea; Antonini Cappellini, Gian Carlo; De Galitiis, Federica; Vitale, Maria Giuseppa; Rastelli, Francesca; Pergolesi, Federica; Berardi, Rossana; Rinaldi, Silvia; Tudini, Marianna; Silva, Rosa Rita; Pireddu, Annagrazia; Atzori, Francesco; Chiari, Rita; Ricciuti, Biagio; De Giglio, Andrea; Iacono, Daniela; Gelibter, Alain; Occhipinti, Mario Alberto; Parisi, Alessandro; Porzio, Giampiero; Fargnoli, Maria Concetta; Ascierto, Paolo Antonio; Ficorella, Corrado; Natoli, Clara
A phase 1 study of mTORC1/2 inhibitor BI 860585 as a single agent or with exemestane or paclitaxel in patients with advanced solid tumors
2020-01-01 de Braud, F.; Machiels, J. -P. H.; Boggiani, D.; Rottey, S. W. H.; Duca, M.; Laruelle, M.; Salvagni, S.; Damian, S.; Lapeire, L. D. F.; Tiseo, M.; Dermine, A.; Ould-Kaci, M.; Braunger, J.; Rascher, J.; Fischer, D.; Hoefler, J.; Mariani, G. L.; Cresta, S.
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer
2013-01-01 De Marinis, F.; Atmaca, A.; Tiseo, M.; Giuffreda, L.; Rossi, A.; Gebbia, V.; D'Antonio, C.; Zotto, L. D.; Al-Batran, S. -E.; Marsoni, S.; Wolf, M.
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale
2022-01-01 Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine
2021-01-01 Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M.
Aberrant expression of PTEN in squamous lung cancer cells: molecular analysis and impact on the synergistic combination of the targeted therapy with BKM120 and Defactinib
2015-01-01 Cavazzoni, A; Giovannetti, E; Alfieri, R; Caraffini, Veronica; Tiseo, M; Sciarrillo, R; Ardizzoni, A; Petronini, Pg.
ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC
2010-01-01 Tiseo, Marcello; Nizzoli, R; Guazzi, ANNA MARIA; Bartolotti, Marco; Gelsomino, F; Majori, Maria; Ferrari, L; DE FILIPPO, Massimo; Silini, Enrico Maria; Ardizzoni, Andrea
Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.
2011-01-01 Nizzoli, R; Tiseo, M; Gelsomino, F; Bartolotti, M; Majori, M; Ferrari, L; DE FILIPPO, Massimo; Rindi, G; Silini, Enrico Maria; Guazzi, A; Ardizzoni, A.
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion
2019-01-01 La Monica, S.; Minari, R.; Cretella, D.; Bonelli, M.; Fumarola, C.; Cavazzoni, A.; Galetti, M.; Digiacomo, G.; Riccardi, F.; Petronini, P. G.; Tiseo, M.; Alfieri, R.
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
2019-01-01 Passaro, A.; Prelaj, A.; Bonanno, L.; Tiseo, M.; Tuzi, A.; Proto, C.; Chiari, R.; Rocco, D.; Genova, C.; Sini, C.; Cortinovis, D.; Pilotto, S.; Landi, L.; Bennati, C.; Camerini, A.; Toschi, L.; Putzu, C.; Cerea, G.; Spitaleri, G.; Cappuzzo, F.; de Marinis, F.
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer
2010-01-01 Bearz, Alessandra; Garassino, Isabella; Tiseo, Marcello; Caffo, Orazio; Soto-Parra, Hector; Boccalon, Massimo; Talamini, Renato; Santoro, Armando; Bartolotti, Marco; Murgia, Viviana; Berretta, Massimiliano; Tirelli, Umberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Pseudocavitation" in thymic carcinoma during treatment with sunitinib | 1-gen-2013 | Tiseo, M.; Rajan, A.; Thomas, A.; Giaccone, G. | |
| 'Turban-like' skull metastasis from pulmonary adenocarcinoma | 1-gen-2017 | Mengoli, M. C.; Rossi, G.; Tiseo, M.; Barbieri, F.; Pifferi, M.; Bertolini, F.; Lococo, F. | |
| 1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy | 1-gen-2021 | Mazzaschi, G.; Scandino, R.; Milanese, G.; Pavone, C.; Maurizio, B.; Silva, M.; Ledda, R.; Minari, R.; Trentini, F.; Buti, S.; Bordi, P.; Leonetti, A.; Quaini, F.; Sverzellati, N.; Romanel, A.; Tiseo, M. | |
| 17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients | 1-gen-2021 | Mazzaschi, G.; Milanese, G.; Moron Dalla Tor, L.; Leo, L.; Balbi, M.; Trentini, F.; Manini, M.; Pavone, C.; Silva, M.; Ledda, R. E.; Minari, R.; Bordi, P.; Buti, S.; Leonetti, A.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
| 209P: SMO mutation is a strong negative prognostic factor in malignant pleural mesothelioma | 1-gen-2016 | Signorelli, D.; Proto, C.; Ganzinelli, M.; Russo, G. L.; Botta, L.; Trama, A.; Pasello, G.; Tiseo, M.; Pelosi, G.; Garassino, M. | |
| 238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors | 1-gen-2022 | Mazzaschi, G.; Tamarozzi, P.; Lorusso, B.; Verzè, M.; Pluchino, M.; Trentini, F.; Dalla Valle, B.; Minari, R.; Perrone, F.; Bordi, P.; Leonetti, A.; Moron Dalla Tor, L.; Leo, L.; Milanese, G.; Balbi, M.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M. | |
| 2PD Monitoring of secondary drug resistance mutations in circulating tumor DNA of patients with advanced ALK positive NSCLC | 1-gen-2016 | Bordi, P.; Del Re, M.; Danesi, R.; Tiseo, M. | |
| A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients? | 1-gen-2021 | Leonetti, A.; Carbone, D.; Gregori, A.; Tiseo, M.; Peters, G. J.; Deng, D.; Giovannetti, E. | |
| A metanalysis on cabozantinib and bone metastases: True story or commercial gimmick? | 1-gen-2020 | Bersanelli, M.; Buti, S.; Ghidini, A.; Tiseo, M.; Petrelli, F. | |
| A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable | 1-gen-2019 | Cortellini, Alessio; Bersanelli, Melissa; Buti, Sebastiano; Cannita, Katia; Santini, Daniele; Perrone, Fabiana; Giusti, Raffaele; Tiseo, Marcello; Michiara, Maria; Di Marino, Pietro; Tinari, Nicola; De Tursi, Michele; Zoratto, Federica; Veltri, Enzo; Marconcini, Riccardo; Malorgio, Francesco; Russano, Marco; Anesi, Cecilia; Zeppola, Tea; Filetti, Marco; Marchetti, Paolo; Botticelli, Andrea; Antonini Cappellini, Gian Carlo; De Galitiis, Federica; Vitale, Maria Giuseppa; Rastelli, Francesca; Pergolesi, Federica; Berardi, Rossana; Rinaldi, Silvia; Tudini, Marianna; Silva, Rosa Rita; Pireddu, Annagrazia; Atzori, Francesco; Chiari, Rita; Ricciuti, Biagio; De Giglio, Andrea; Iacono, Daniela; Gelibter, Alain; Occhipinti, Mario Alberto; Parisi, Alessandro; Porzio, Giampiero; Fargnoli, Maria Concetta; Ascierto, Paolo Antonio; Ficorella, Corrado; Natoli, Clara | |
| A phase 1 study of mTORC1/2 inhibitor BI 860585 as a single agent or with exemestane or paclitaxel in patients with advanced solid tumors | 1-gen-2020 | de Braud, F.; Machiels, J. -P. H.; Boggiani, D.; Rottey, S. W. H.; Duca, M.; Laruelle, M.; Salvagni, S.; Damian, S.; Lapeire, L. D. F.; Tiseo, M.; Dermine, A.; Ould-Kaci, M.; Braunger, J.; Rascher, J.; Fischer, D.; Hoefler, J.; Mariani, G. L.; Cresta, S. | |
| A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer | 1-gen-2013 | De Marinis, F.; Atmaca, A.; Tiseo, M.; Giuffreda, L.; Rossi, A.; Gebbia, V.; D'Antonio, C.; Zotto, L. D.; Al-Batran, S. -E.; Marsoni, S.; Wolf, M. | |
| A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale | 1-gen-2022 | Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea | |
| A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine | 1-gen-2021 | Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M. | |
| Aberrant expression of PTEN in squamous lung cancer cells: molecular analysis and impact on the synergistic combination of the targeted therapy with BKM120 and Defactinib | 1-gen-2015 | Cavazzoni, A; Giovannetti, E; Alfieri, R; Caraffini, Veronica; Tiseo, M; Sciarrillo, R; Ardizzoni, A; Petronini, Pg. | |
| ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC | 1-gen-2010 | Tiseo, Marcello; Nizzoli, R; Guazzi, ANNA MARIA; Bartolotti, Marco; Gelsomino, F; Majori, Maria; Ferrari, L; DE FILIPPO, Massimo; Silini, Enrico Maria; Ardizzoni, Andrea | |
| Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer. | 1-gen-2011 | Nizzoli, R; Tiseo, M; Gelsomino, F; Bartolotti, M; Majori, M; Ferrari, L; DE FILIPPO, Massimo; Rindi, G; Silini, Enrico Maria; Guazzi, A; Ardizzoni, A. | |
| Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion | 1-gen-2019 | La Monica, S.; Minari, R.; Cretella, D.; Bonelli, M.; Fumarola, C.; Cavazzoni, A.; Galetti, M.; Digiacomo, G.; Riccardi, F.; Petronini, P. G.; Tiseo, M.; Alfieri, R. | |
| Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations | 1-gen-2019 | Passaro, A.; Prelaj, A.; Bonanno, L.; Tiseo, M.; Tuzi, A.; Proto, C.; Chiari, R.; Rocco, D.; Genova, C.; Sini, C.; Cortinovis, D.; Pilotto, S.; Landi, L.; Bennati, C.; Camerini, A.; Toschi, L.; Putzu, C.; Cerea, G.; Spitaleri, G.; Cappuzzo, F.; de Marinis, F. | |
| Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer | 1-gen-2010 | Bearz, Alessandra; Garassino, Isabella; Tiseo, Marcello; Caffo, Orazio; Soto-Parra, Hector; Boccalon, Massimo; Talamini, Renato; Santoro, Armando; Bartolotti, Marco; Murgia, Viviana; Berretta, Massimiliano; Tirelli, Umberto |